CLEAR Sepsis Clinical Study
Status: | Recruiting |
---|---|
Conditions: | Hospital |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/17/2019 |
Start Date: | June 29, 2017 |
End Date: | February 28, 2020 |
Contact: | Jurandir Araujo, BA |
Email: | jurandir_araujo@edwards.com |
Phone: | 949-250-5469 |
Noninvasive Hemodynamic Monitoring Utilizing ClearSight TM System in Suspected Sepsis Patients Presenting to the Emergency Department (CLEAR SEPSIS)
To investigate the relationship between initial ClearSight™ derived hemodynamic parameters
and outcomes (death, ongoing organ dysfunction or delayed ICU admission) in patients with
acute infection and possible sepsis, with a focus on venous blood lactate (< 2.0, 2.0-3.9,
and ≥ 4.0 mmol/dL) and hemodynamic subgroups, using ED patients presenting with minor
infections or asthma/COPD exacerbations as controls (henceforth referred to as Sepsis Mimic
Group).
and outcomes (death, ongoing organ dysfunction or delayed ICU admission) in patients with
acute infection and possible sepsis, with a focus on venous blood lactate (< 2.0, 2.0-3.9,
and ≥ 4.0 mmol/dL) and hemodynamic subgroups, using ED patients presenting with minor
infections or asthma/COPD exacerbations as controls (henceforth referred to as Sepsis Mimic
Group).
Venous Blood Lactate Groups
Inclusion Criteria:
- ≥ 18 years of age at the time of enrollment
- Any combination of acute symptoms and signs that the treating ED physician, after
initial history and physical examination, attributes to a systemic infection
- ED Physician confirms likely hospital admission (> 50%) due to suspicion of infection
- ED Physician confirms intention to order both blood cultures and venous blood lactate
levels
- Ability to enroll patient and begin ClearSight™ monitoring within three (3) hours of
ED presentation
Exclusion Criteria:
- Initial venous blood lactate measured > 3 hours after ED arrival
- Pre-existing infection for which patient is being treated with antibiotics as an
outpatient
- Prisoners
- Pregnant women
- Any previous medical condition with life expectancy of < 3 months (patients with ESRD
and heart failure are not excluded)
- DNR or comfort care order preexisting to ED visit or established in the ED
- Palliative care or hospice consult in the ED
- Known severe aortic insufficiency
- Known history of Raynaud's disease
- Poor follow-up candidate in the opinion of the Investigator
- Current or planned enrollment in an investigational trial that in the opinion of the
Investigator may significantly affect hemodynamic data collection.
Control Sepsis Mimic
Inclusion Criteria:
- ≥18 years of age at the time of enrollment
- Presents to the ED with a chief complaint consistent with a minor infection (upper
respiratory infection, soft tissue infection, viral infection) or an asthma or COPD
exacerbation on whom the treating physician is not ordering labs for blood cultures or
lactate levels
- Ability to enroll patient and begin ClearSight™ monitoring within three (3) hours of
ED presentation.
Exclusion Criteria:
- Pre-existing infection for which patient is being treated with antibiotics as an
outpatient
- Prisoners
- Pregnant women
- Any previous medical condition with life expectancy of < 3 months (patients with ESRD
and heart failure are not excluded)
- DNR or comfort care order preexisting to ED visit or established in the ED
- Palliative care or hospice consult in the ED
- Known severe aortic insufficiency
- Known history of Raynaud's disease
- Poor follow-up candidate in the opinion of the Investigator
- Current or planned enrollment in an investigational trial that in the opinion of the
Investigator may significantly affect hemodynamic data collection.
- Treating physician is planning on ordering either a lactate or blood cultures on the
patient.
We found this trial at
5
sites
Royal Oak, Michigan 48314
Principal Investigator: Robert Swor, DO
Phone: 248-898-3455
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
44201 Dequindre Road
Troy, Michigan 48085
Troy, Michigan 48085
Principal Investigator: Aveh Bastani, MD
Phone: 248-964-6055
Click here to add this to my saved trials